Our co-founder and CEO @ckingsford will give a talk during the Sept. 24th 11am session at the virtual summit "Data Management for Precision Medicine: Data Models for Tuning and Validation of Deep Learning" held 9/24-25.
Register at https://t.co/kqKKTearyj
🎉 Congratulations to our CEO and co-founder, Dr. Carl Kingsford on becoming an ISCB Fellow! 🌟 #ComputationalBiology
Check out the full announcement https://t.co/viiVzf5fO6
🎉Exciting News!🧬Ocean Genomics and Geneyx were awarded a BIRD Foundation grant to develop cutting-edge multi-omic software that combines DNA and RNA to improve structural variant detection, disease diagnosis, and drug target identification! https://t.co/dO4vR0wbzr
Ocean Genomics is delighted to partner with @Accenture to bring improvements in
transcriptomics for drug discovery to biopharma clients at scale.
https://t.co/79OWAdkGtf
Join us in congratulating our very own Gaurav Sharma, a co-author on the recent cover article for Science Translational Medicine!
He is the lead computational biologist in research elucidating metastasis in Triple Negative Breast Cancer.
Read the paper https://t.co/OKjS2k4wvM
ONT Long Read Support: Use Salmon to quantify ONT long-reads (both cDNA and direct RNA) which now has an enhanced alignment error model specially designed to work with long-reads.
Check out the new and upcoming Salmon tools and features from Ocean https://t.co/QtLzyKy56S
NEW Quantification from Genomic Alignments Support: Mudskipper converts genomic alignments in BAM/SAM formats to transcriptomic alignments in BAM format or RAD format.
See new and upcoming Salmon tools and features from Ocean https://t.co/QtLzyKy56S
Check it out! https://t.co/6f8KVQVsWi
Ocean Genomics has been awarded a grant from the Chan Zuckerberg Initiative for an amazing new internship program here at Ocean!
Thank you @cziscience for supporting DEI programs!
Ocean Genomics leveraged its AI-driven transcriptome analysis and biomarker discovery platform, to identify a potential predictive RNA-seq driven biomarker in BRAF V600E mt mCRC. See our story and #ASCO21 abstract here: https://t.co/5GahAdVBoh #RNA#precisionmedicine
Ocean Genomics discovers a potential predictive RNA-seq biomarker for the efficacy of eribulin in BRAF V600E mt mCRC in collaboration with Aichi Medical Center, Nagoya, the National Cancer Center Hospital East, Kashiwa, and other leading centers in Japan: https://t.co/JlU6Oc25z2
Using all the information generated by txome. ai, such as gene and transcript quantification, structural variants etc., multiple machine learning models are run to predict the labels of interest. https://t.co/bhfsLgk1Gu #RNAanalysis#genomics#transcriptomics
txome. ai's functional profiling provides finer understanding of biological differences between different conditions using Gene Ontology and pathway databases: https://t.co/mGm9Uk4w8k #RNAanalysis#drugdevelopment#drugdiscovery
Thank you to @EdithPerezMD for joining Ocean Genomics’ scientific advisory board. Edith is a world-renowned translational researcher and cancer specialist. Meet the rest of the board: https://t.co/wR9KWAii8Y #translationalresearch#biomarkers#rnaseq
Gene expression analysis on tumor tissue RNA can deliver critical information for targeted therapy and immunotherapy,” Dr. Woong Yang Park, CEO, Geninus. Read more about the partnership between Ocean Genomics & Geninus: https://t.co/UepwFn8lAI #biomarkers#oncology#immunotherapy
Ocean Genomics and Geninus just announced a strategic partnership to co-develop RNA-based biomarkers and advance research and clinical applications with hospital, academic, and biotechnology clients. https://t.co/xiMLUULAWc #genomics#RNA#biomarkers
“Ocean Genomics’ expertise in AI and computational method development, together with Geninus’ translational experts and access to data is a powerful combination. Read more about the partnership: https://t.co/RQBUoPcgh8 #biomarkers#RNA#immunotherapy